1. Uptake, experiences and barriers to cervical screening for trans and non‐binary people in Aotearoa New Zealand.
- Author
-
Carroll, Rona, Tan, Kyle K. H., Ker, Alex, Byrne, Jack L., and Veale, Jaimie F.
- Subjects
INJURY complications ,DELAYED diagnosis ,PAIN ,EARLY detection of cancer ,NONBINARY people ,FEAR ,MEDICAL care costs ,PSYCHOSOCIAL factors ,ACCESS to information ,DESCRIPTIVE statistics ,RESEARCH funding ,CERVIX uteri tumors ,ANXIETY ,TRANS men ,DATA analysis software ,TRANSGENDER people - Abstract
Background: Little is known about experiences and barriers for trans and non‐binary (TGNB) people eligible for cervical screening in Aotearoa New Zealand. Aims: To identify uptake, barriers and reasons for delaying cervical cancer screening among TGNB people in Aotearoa. Materials and Methods: The 2018 Counting Ourselves data on TGNB people assigned female at birth aged 20–69 years who had ever had sex, were analysed to report on experiences of those who were eligible for cervical screening (n = 318). Participants answered questions about whether they had taken part in cervical screening and reasons behind any delays in receiving the test. Results: Trans men were more likely than non‐binary participants to report that they did not require cervical screening or were unsure if they needed it. For those who had delayed cervical screening, 30% did so due to feeling worried about how they would be treated as a trans or non‐binary person and 35% due to another reason. Other reasons for delay related to general and gender‐related discomfort, previous traumatic experiences, anxiety or fear of the test and pain. Material barriers to access included cost and lack of information. Conclusions: The current cervical screening program in Aotearoa does not consider the needs of TGNB people, leading to delayed and reduced uptake of cervical screening. Health providers require education on the reasons TGNB people delay or avoid cervical screening in order to provide appropriate information and affirmative healthcare environments. The human papillomavirus self‐swab may address some of the existing barriers. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF